Advertisement

Index by author

March 01, 1994; Volume 22,Issue 2

  1. Madan, A

    1. NADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.
      A Madan and M D Faiman
      Drug Metabolism and Disposition March 1994, 22 (2) 324-330;

  2. Mahadevan, S

    1. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
      V Fischer, A E Vickers, F Heitz, S Mahadevan, J P Baldeck, P Minery and R Tynes
      Drug Metabolism and Disposition March 1994, 22 (2) 269-274;

  3. Mammarella, M L

    1. Salicylate inhibits the renal transport of inorganic sulfate in rat membrane vesicle preparations.
      I M Darling, M L Mammarella, Q Chen and M E Morris
      Drug Metabolism and Disposition March 1994, 22 (2) 318-323;

  4. Mangos, S

    1. Induction and regulation of CYP2E1 in murine liver after acute and chronic acetone administration.
      P G Forkert, Z M Redza, S Mangos, S S Park and S P Tam
      Drug Metabolism and Disposition March 1994, 22 (2) 248-253;

  5. Maniglier-poulet, C

    1. Solvolytic formation of 1,2-dichloro-3,4-epoxybutane from butadiene monoxide under physiological conditions.
      X Cheng, C Maniglier-Poulet, D Ross and J A Ruth
      Drug Metabolism and Disposition March 1994, 22 (2) 206-210;

  6. Manzini, S

    1. Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.
      O Agostini, G Bonacchi, G Coppini, E Toja, A Triolo, S Manzini, G Pieraccini and G Moneti
      Drug Metabolism and Disposition March 1994, 22 (2) 259-268;

  7. Marathe, P H

    1. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
      P H Marathe, D D Shen and W L Nelson
      Drug Metabolism and Disposition March 1994, 22 (2) 237-247;

  8. Markham, P M

    1. Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application.
      V K Khetarpal, P M Markham and J A Ziemniak
      Drug Metabolism and Disposition March 1994, 22 (2) 216-223;

  9. Mayol, R F

    1. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
      R F Mayol, C A Cole, G M Luke, K L Colson and E H Kerns
      Drug Metabolism and Disposition March 1994, 22 (2) 304-311;

  10. Mine, T

    1. Pharmacokinetics of SM-10888 and its metabolites depending on their physicochemical properties.
      M Yabuki, T Mine, K Iba, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition March 1994, 22 (2) 294-297;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement